Abstract
For infertile women with anti-sperm antibodies (ASAs), treatments such as condom therapy, abstinence, and steroid suppression therapy have been applied, and they resulted in a generally poor consequence. Some success has been achieved with intrauterine insemination (IUI), but not when serum ASA levels are high. There have been some reports that described unsuccessful application of IVF-ET for the treatment of infertile women with ASA. They presumed that these results underline the importance of using replacement serum in cases where the wife has significant sperm antibody levels in her serum.
After paying a special attention to remove the ASA adhered to cumulus cells around oocytes and avoiding the contamination of blood in the aspirated follicular fluid and moreover removing the antibodies in the follicular fluid by transferring oocytes several times to the new culture medium with replacement serum that was added to the culture medium, fertilization and cleavage rates of mature oocytes from the patients with ASA were not different from those in patients without the antibodies. Therefore, each infertile woman entering an IVF-ET program should have the ASA assay performed as a preliminary screening. It is also important that substitution of the patients’ serum by replacement serum in the fertilization and embryo growth media may prove to be an effective means of improving IVF treatment for women with ASA.
For infertile women with sperm-immobilizing antibodies, it is important to assess the SI50 titers by the quantitative method to select appropriate treatments. A strategy for the treatment of infertile women with sperm-immobilizing antibodies was suggested. The strategy emphasizes the importance of assessing SI50 titers to select treatments for infertile women with sperm-immobilizing antibodies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kobayashi S, Bessho T, Shigeta M, Koyama K, Isojima S. Correlation between quantitative antibody titers of sperm immobilizing antibodies and pregnancy rates by treatments. Fertil Steril. 1990;54:1107–13.
Kamada M, Daitoh T, Hasebe H, Irahara M, Yamano S, Mori T. Blocking of human fertilization in vitro by sera with sperm-immobilizing antibodies. Am J Obstet Gynecol. 1985;153:328–31.
Tsukui S, Noda Y, Fukuda A, Matsumoto H, Tatsumi K, Mori T. Blocking effect of sperm immobilizing antibodies on sperm penetration of human zonae pellucidae. J In Vitro Fert Embryo Transf. 1988;5:123–8.
Shibahara H, Shigeta M, Koyama K, Burkman LJ, Alexander NJ, Isojima S. Inhibition of sperm-zona pellucida tight binding by sperm immobilizing antibodies as assessed by the hemizona assay (HZA). Acta Obstet Gynaecol Jpn. 1991;43:237–8.
Bandoh R, Yamano S, Kamada M, Daitoh T, Aono T. Effect of sperm-immobilizing antibodies on the acrosome reaction of human spermatozoa. Fertil Steril. 1992;57:387–92.
Shibahara H, Burkman LJ, Isojima S, Alexander NJ. Effects of sperm-immobilizing antibodies on sperm-zona pellucida tight binding. Fertil Steril. 1993;60:533–9.
Shibahara H, Shigeta M, Inoue M, Hasegawa A, Koyama K, Alexander NJ, Isojima S. Diversity of the blocking effects of antisperm antibodies on fertilization in human and mouse. Hum Reprod. 1996;11:2595–9.
Shibahara H, Mitsuo M, Ikeda Y, Shigeta M, Koyama K. Effects of sperm immobilizing antibodies on pregnancy outcome in infertile women treated with IVF-ET. Am J Reprod Immunol. 1996;36:96–100.
Shibahara H, Hirano Y, Shiraishi Y, Shimada K, Kikuchi K, Suzuki T, Takamizawa S, Suzuki M. Effects of in vivo exposure to eggs with sperm-immobilizing antibodies in follicular fluid on subsequent fertilization and embryo development in vitro. Reprod Med Biol. 2006;5:137–43.
Taneichi A, Shibahara H, Hirano Y, Suzuki T, Obara H, Fujiwara H, Takamizawa S, Sato I. Sperm immobilizing antibodies in the sera of infertile women cause low fertilization rates and poor embryo quality in vitro. Am J Reprod Immunol. 2002;47:46–51.
Pexieder T, Boillat E, Janecek P. Antisperm antibodies and in vitro fertilization failure. J In Vitro Fertil Embryo Transf. 1985;2:229–32.
Ackerman SB, Wortham JW, Swanson RJ. An indirect enzyme-linked immunosorbent assay (ELISA) for the detection and quantitation of antisperm antibodies. Am J Reprod Immunol. 1981;1:199–205.
Clarke GN, Lopata A, Johnston WIH. Effects of sperm antibodies in females on human in vitro fertilization. Fertil Steril. 1986;46:435–41.
Bronson RA, Cooper GW, Rosenfeld DL. Sperm-specific isoantibodies and autoantibodies inhibit the binding of human sperm to the human zona pellucida. Fertil Steril. 1982;38:724–9.
Mandelbaum SL, Diamond MP, DeCherney AH. Relationship of antisperm antibodies to oocyte fertilization in in vitro fertilization-embryo transfer. Fertil Steril. 1987;47:644–51.
Isojima S, Li TS, Ashitaka Y. Immunologic analysis of sperm-immobilizing factor found in sera of women with unexplained sterility. Am J Obstet Gynecol. 1968;101:677–83.
Isojima S, Tsuchiya K, Koyama K, Tanaka C, Naka O, Adachi H. Further studies on sperm-immobilizing antibody found in sera of unexplained cases of sterility in women. Am J Obstet Gynecol. 1972;112:199–207.
Koyama K. Gamete immunology: infertility and contraception. Reprod Immunol Biol. 2009;24:1–17.
Yovich JL, Stanger JD, Kay D, Boettcher B. In-vitro fertilisation of oocytes from women with serum antisperm antibodies. Lancet. 1984;1(8373):369–70.
Kibrick S, Belding DL, Merrill B. A sensitive gelatin agglutination test for detecting antisperm agglutinins. Fertil Steril. 1952;3:430–8.
Friberg J. A simple and sensitive micro-method for demonstration of sperm-agglutinating activity in serum from infertile men and women. Acta Obstet Gynecol Scand Suppl. 1974;36:21–9.
Ackermann SB, Graff D, van Uem JFHM, Swanson RJ, Veeck LL, Acosta AA, Garcia JE. Immunologic infertility and in vitro fertilization. Fertil Steril. 1984;42:474–7.
Hellema HW, Samuel T, Rumke P. Sperm autoantibodies as a consequence of vasectomy. II. Long-term follow-up studies. Clin Exp Immunol. 1979;38:31–6.
Clarke GN, McBain JC, Lopata A, Johnston WIH. In vitro fertilization results for women with antisperm antibodies in plasma and follicular fluid. Am J Reprod Immunol. 1985;8:130–1.
Sugimoto Y, Hasegawa A, Yokoyama K, Ikeda Y, Bessho T, Shigeta M, Ikuma K, Taira S, Koyama K, Isojima S. Successful application of in vitro fertilization and embryo replacement in the treatment of infertile women with sperm immobilizing antibody. Acta Obstet Gynaecol Jpn. 1987;38:1135–6.
Isojima S, Koyama K. Quantitative estimation of sperm immobilizing antibody in the sera of women with sterility of unknown etiology; the 50% sperm immobilization unit (SI50). Excerpta Medica Int Congr Ser. 1974;370:10–5.
Koyama K, Kubota K, Ikuma K, Shigeta M, Isojima S. Application of the quantitative sperm immobilization test for follow-up study of sperm-immobilizing antibody in the sera of sterile women. Int J Fertil. 1988;33:201–6.
Daitoh T, Kamada M, Yamano S, Murayama S, Kobayashi T, Maegawa M, Aono T. High implantation rate and consequently high pregnancy rate by in vitro fertilization-embryo transfer treatment in infertile women with antisperm antibody. Fertil Steril. 1995;63:87–91.
Taya T, Shibahara H, Komori S, Shigeta M, Koyama K, Isojima S. Changes of sperm-immobilizing antibody activities during pregnancy and its passage through placenta. Adv Obstet Gynecol. 1992;44:129–31. (in Japanese).
Tsuji Y, Clausen H, Nudelman E, Kaizu T, Hakomori S, Isojima S. Human sperm carbohydrate antigens defined by an antisperm human monoclonal antibody derived from an infertile woman bearing antisperm antibodies in her serum. J Exp Med. 1988;168:343–56.
Kameda K, Tsuji Y, Koyama K, Isojima S. Comparative studies of the antigens recognized by sperm-immobilizing monoclonal antibodies. Biol Reprod. 1992;46:349–57.
Koyama K, Ikuma K, Kubota K, Isojima S. Effects of antisperm antibodies on sperm migration through cervical mucus. Excerpta Med Int Congr Ser. 1980;512:705–8.
Shibahara H, Shiraishi Y, Hirano Y, Kasumi H, Koyama K, Suzuki M. Relationship between level of serum sperm immobilizing antibody and its inhibitory effect on sperm migration through cervical mucus in immunologically infertile women. Am J Reprod Immunol. 2007;57:142–6.
Shibahara H, Shigeta M, Toji H, Koyama K. Sperm immobilizing antibodies interfere with sperm migration from the uterine cavity through the fallopian tubes. Am J Reprod Immunol. 1995;34:120–4.
Shibahara H, Koriyama J, Shiraishi Y, Hirano Y, Suzuki M, Koyama K. Diagnosis and treatment of immunologically infertile women with sperm-immobilizing antibodies in their sera. J Reprod Immunol. 2009;83:139–44.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Shibahara, H. (2022). Assisted Reproductive Technology (ART) as a Treatment for Infertile Women with Anti-sperm Antibody (ASA). In: Shibahara, H., Hasegawa, A. (eds) Gamete Immunology. Springer, Singapore. https://doi.org/10.1007/978-981-16-9625-1_6
Download citation
DOI: https://doi.org/10.1007/978-981-16-9625-1_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-9624-4
Online ISBN: 978-981-16-9625-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)